Segall Bryant & Hamill LLC raised its stake in Ingevity Corporation (NYSE:NGVT – Free Report) by 1.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,298,661 shares of the company’s stock after buying an additional 15,451 shares during the quarter. Ingevity accounts for about 1.0% of Segall Bryant & Hamill LLC’s portfolio, making the stock its 7th largest position. Segall Bryant & Hamill LLC owned approximately 3.56% of Ingevity worth $71,673,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors also recently modified their holdings of the company. Allianz Asset Management GmbH bought a new stake in shares of Ingevity in the 3rd quarter valued at $1,670,000. Teacher Retirement System of Texas lifted its holdings in Ingevity by 82.1% during the second quarter. Teacher Retirement System of Texas now owns 36,312 shares of the company’s stock worth $1,565,000 after acquiring an additional 16,366 shares in the last quarter. Squarepoint Ops LLC acquired a new position in Ingevity in the second quarter valued at about $1,279,000. Brandywine Global Investment Management LLC acquired a new position in Ingevity in the second quarter valued at about $2,767,000. Finally, American Century Companies Inc. increased its holdings in shares of Ingevity by 15.6% in the second quarter. American Century Companies Inc. now owns 1,707,273 shares of the company’s stock worth $73,566,000 after acquiring an additional 230,525 shares in the last quarter. 91.59% of the stock is currently owned by institutional investors and hedge funds.
Ingevity Trading Down 0.5%
Ingevity stock opened at $71.70 on Tuesday. The company has a market cap of $2.53 billion, a price-to-earnings ratio of -15.42 and a beta of 1.31. The firm has a 50-day moving average of $67.47 and a 200-day moving average of $59.30. The company has a debt-to-equity ratio of 39.10, a current ratio of 1.33 and a quick ratio of 0.79. Ingevity Corporation has a one year low of $28.49 and a one year high of $77.46.
Wall Street Analysts Forecast Growth
Several equities analysts have recently weighed in on NGVT shares. Wall Street Zen upgraded Ingevity from a “buy” rating to a “strong-buy” rating in a report on Sunday. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Ingevity in a research note on Thursday, January 22nd. Jefferies Financial Group reissued a “buy” rating and set a $82.00 price objective on shares of Ingevity in a research report on Thursday. Zacks Research raised shares of Ingevity to a “hold” rating in a research report on Tuesday, December 16th. Finally, BMO Capital Markets reiterated an “outperform” rating and set a $83.00 target price on shares of Ingevity in a report on Monday. Two equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $80.00.
Check Out Our Latest Analysis on NGVT
Ingevity Company Profile
Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.
The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.
Recommended Stories
- Five stocks we like better than Ingevity
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- I’m 70 With $1.5M: Would Converting $120K a Year to a Roth Be Smart or a Costly Mistake? (Ask An Advisor)
- ALERT: Drop these 5 stocks before the market opens tomorrow!
Want to see what other hedge funds are holding NGVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ingevity Corporation (NYSE:NGVT – Free Report).
Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.
